Additionally, for individuals with type 2 diabetes, obesity, and heart failure with preserved ejection fraction, GLP-1 receptor agonists are advised to manage glucose and alleviate heart failure symptoms
The compound is the same synthetic triple receptor agonist at GIPR, GLP-1R and GCGR across every vial size, molecular formula CHNO, molecular weight 4731.3 g/mol, CAS 2381089-83-2
The news around GLP-1s tends to read like a highlight reel
There is a loss of time for patient care and a huge increase in time burden outside the visit for doctors and pharmacists. Another major insurance change coming next year will affect another large swath of Dushays patients: In January, BCBS Massachusetts will be excluding all GLP-1s from coverage for treatment of obesity, reserving coverage for these drugs only when indicated to treat type 2 diabetes
Glucose is a large molecule
Reta is intended strictly for laboratory research and is not for human consumption